• share
• favorite_border

• share
• favorite_border

Like diabetes, colon cancer may be caused in part by the loss of one hormone, suggesting hormone replacement therapy could stall cancer formation.

• share
• favorite_border

Tumor cells isolated from the blood of patients with triple negative breast cancer reveal similar cancer-driving mutations as those detected from standard biopsy, suggesting that circulating cells could one day replace tissue biopsies

• share
• favorite_border

A new discovery suggests that the number of human genomic loci that might be coding for tRNAs is nearly double what is currently known.

• share
• favorite_border

Scientists from Thomas Jefferson University and the National Institutes of Health come one step closer to understanding the difficulty of treating joint infection. Biofilm formation plays a role.

• share
• favorite_border

MicroRNA isoforms show population-specific and gender-specific signatures – a finding that could affect how researchers view and study microRNAs

• share
• favorite_border

Thomas Jefferson University’s Ebola vaccine is one of the front runners of those currently in development.

• share
• favorite_border

• share
• favorite_border

African American men are one population that may be harmed by new guidelines that favor observation over treatment of early-stage prostate cancer.

• share
• favorite_border

A new immunotoxin works by getting shuttled into cancer cells, selectively destroying colon cancer, thanks to a quirk of biology

• share
• favorite_border

Two birds with one stone: A novel and broad Ebola vaccine in humans or with specially engineered cows could help researchers develop large quantities of Anti-Ebola serum and protect humans against filoviruses.

• share
• favorite_border

• share
• favorite_border

The study in the postoperative radiation oncology field to show that molecular signature of patient's tumor can help stratify patients requiring additional treatment.

• share
• favorite_border

Thomas Jefferson University joins an international genomic medicine collaborative to help offer the newest innovations in cancer care through clinical trials.

• share
• favorite_border

Infusing a saltier saline solution during and after surgery decreases overall complication rate for a complex procedure

• share
• favorite_border

Settling a long-time debate, researchers show that sewing up a C-section skin incision with sutures leads to fewer complications than using surgical staples.

• share
• favorite_border

The so called fatty liver disease that long time drinkers develop may extend to the lung in a newly discovered side effect of drinking in rats that researchers are calling fatty lung disease.

• share
• favorite_border

Calorie restriction during treatment for breast cancer changes cellular programming in a way that lowers the chance of metastases in mice.

• share
• favorite_border

Non-invasive focused ultrasound thermal therapy reduces pain from bone metastases

• share
• favorite_border

Based on the Patient Centered Medical Home, the NCQA has bestowed a new designation for two Thomas Jefferson University specialty practices.

• share
• favorite_border

Researchers suspect that many cancer vaccines fail because the immune cells that would destroy the tumor are actively suppressed. Now, researchers at Thomas Jefferson University have found that a single cell type may be to blame for the suppression, paving the way to better cancer vaccine design.

• share
• favorite_border

Researchers have found a common link between muscle weakness in alcoholics and mitochondrial disease: mitochondria that are unable to self-repair. The research could lead to both a new diagnostics for mitochondrial disease and a new drug target.

• share
• favorite_border

• share
• favorite_border

A certain class of antibiotics prompts cells to produce low levels of novel self proteins that could trigger an autoimmune disease.

• share
• favorite_border

A derivative of vitamin A, known as retinoic acid, found abundantly in sweet potato and carrots, helps turn pre-cancer cells back to normal healthy breast cells, which may help explain why some clinical studies have been unable to see a benefit of vitamin A on cancer: the vitamin doesn’t appear to change the course of full-blown cancer, only pre-cancerous cells, and only works at a very narrow dose.

• share
• favorite_border

Combining radiation with immnotherapy can boost cancer killing. Now a team from Thomas Jefferson University has shown that the boost works best when the therapies are sequenced correctly.

• share
• favorite_border

Genomic testing that determines the molecular subtype of a woman’s breast cancer provides a more precise prognosis and valuable guidance about the most effective avenue of treatment.

• share
• favorite_border

A drug now used to treat a type of lymphoma has shown surprising benefit in preclinical studies of inflammatory breast cancer

• share
• favorite_border

Occupational therapy helps children with autism improve their ability to perform everyday better than standard behavioral therapy.

• share
• favorite_border

Thomas Jefferson University is developing a single dose rabies and contraceptive vaccine to reduce the infection's human mortality rates worldwide as part of their Grand Challenges Explorations award, an initiative funded by the Bill & Melinda Gates Foundation.

• share
• favorite_border

Researchers find a genetic difference in blood clotting mechanisms, which could help explain some of the racial health disparity in heart disease.

• share
• favorite_border

• share
• favorite_border

• share
• favorite_border

The Department of Medicine at Thomas Jefferson University has been named a Comprehensive Hypertension Center by the American Society of Hypertension (ASH). Jefferson is one of only five in the country to earn top recognition for its advanced diagnosis, evaluation and treatment of complex hypertension and associated disorders.

• share
• favorite_border

• share
• favorite_border

New, regional concussion center will offer top, multidisciplinary concussion care--neurology, opthalmology, psychiatry, etc. through a collaboration of Thomas Jefferson University Hospital, Rothman Institute, and Wills Eye Hospital.

• share
• favorite_border

When the pros and cons of prostate cancer treatment are spelled out using an online interactive program, more patients choose active surveillance over therapy.

• share
• favorite_border

A hologram-like display of a patient’s organs based on molecular PET/CT images helps surgeons plan surgery by allowing them to see detailed anatomical structure, peel away layers of tissue, and see all sides of a tumor, before entering the operating room to excise it.

• share
• favorite_border

A team of Thomas Jefferson University researchers has shown that an HDL receptor found on breast cancer cells may be responsible for making this cancer more aggressive, proposing a new molecular target that could help treat the disease.

• share
• favorite_border

Renowned national and international leaders in diabetes prevention, treatment and research will descend on Philadelphia for the Second Annual Diabetes Symposium: New Advances and Innovations, a one-day symposium on advancing patient care at the intersection of diabetes and cardiovascular disease, cancer, sexual health and new this year, physicians and diabetes educators will address the latest advances in managing obesity in the diabetic patient. The symposium is organized and lead by Serge Jabbour, M.D., director of the Division of Endocrinology, Diabetes Center, and Comprehensive Weight Management Program, and Jeffrey Miller, M.D., clinical director, Division of Endocrinology and Co-director of the Thyroid and Parathyroid Center at Jefferson and will commence on Friday, October 11th from 7:30 a.m. to 5:30 p.m. in the Dorrance H. Hamilton Building on the Thomas Jefferson University campus.

• share
• favorite_border

Researchers with Jefferson Orthopedics are using their experience and expertise in post-traumatic joint stiffness to develop treatments that could aid in optimal recovery and restoration of joint function for members of the military who sustain traumatic combat or combat-related injuries.

• share
• favorite_border

Lessons learned from California's health insurance marketplace, similar to the health insurance exchanges under the Affordable Care Act.

• share
• favorite_border

Jefferson School of Population Health researcher Robert Lieberthal, PhD develops a new way to measure hospital quality - and patient satisfaction plays only a minor role. Relevant to the Patient Protection and Affordable Care Act, which links patient satisfaction to hospital reimbursement.

• share
• favorite_border

James C. Krieg, M.D., has joined the Rothman Institute at Jefferson as Chief of Orthopedic Trauma and Fracture Care, and Professor of Orthopedic Surgery at Jefferson Medical College.

• share
• favorite_border

Raymond Penn, Ph.D., the new director of the Center for Translational Medicine and Director of Pulmonary Research in the newly established Jefferson-Jane and Leonard Korman Lung Center has been awarded a research grant from the National Heart, Lung, and Blood Institute to identify new therapies for the treatment of asthma.

• share
• favorite_border

Jefferson Radiation Oncologist, Nicole Simone, M.D., was recently awarded one of 21 Young Investigator Awards from the Prostate Cancer Foundation (PCF). The award, in the amount of $225,000, will be used to further her research in caloric restriction to decrease tumor growth and metastases in prostate cancer patients. Young investigator awards support the most innovative minds in the field of prostate cancer research and are designed to promote long-term careers in prostate cancer research by providing three-year grants for transformational research focused on prostate cancer advances and new treatments to improve patient outcomes.

• share
• favorite_border

Thomas Jefferson University Hospital has been named to U.S. News & World Report’s most exclusive and influential list: Best Hospitals 2013-14 Honor Roll. Jefferson’s first-ever honor roll ranking at number 17, places it among an elite group of the nation’s top hospitals, chosen for the breadth and depth of clinical excellence.

• share
• favorite_border

Recent studies by researchers at Thomas Jefferson University’s Kimmel Cancer Center have shown a gene known to coordinate initial development of the eye (EYA1) is a powerful breast tumor promoter in mice. The gene EYA1 was also shown to be overexpressed in a genetic breast cancer subtype called luminal B.

• share
• favorite_border

Researchers from Thomas Jefferson University’s Kimmel Cancer Center have discovered that decorin, a naturally occurring protein that circulates in the blood, acts as a potent inhibitor of tumor growth modulating the tumor microenvironment.

• share
• favorite_border

Transformative physician leader for USF Health returns to Philadelphia to oversee new structure.